Finding an LSAT prep course that actually works shouldn’t feel like another test. With 176,000 students recently sitting for the Law School Admission Test, all competing for the same coveted law ...

When Jeff Albers joined Blueprint Medicines in 2014, the private company was a clinical-stage biotech. Now, the helmsman is handing down the reins after steering the firm through an IPO and two drug ...

Alexis Borisy, the founder of multiple biotech companies and self-dubbed “man of many hats,” may have to reduce two of his many duties. The Blueprint Medicines co-founder lost a majority vote for his ...

Blueprint Medicines is cutting funding to its clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with similar preclinical breast cancer-focused therapies. The biopharma has three ...

This study will create a blueprint for a sustainable infrastructure to implement preventive interventions that promote behavioral health. It will also identify funding needs and strategies to support ...